Cardinal Health Inc. ($CAH) Stock Forecast: Down 0.5% Today

What is Cardinal Health Inc.?

CAH (Cardinal Health) is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices worldwide.

Why is Cardinal Health Inc. going down?

CAH stock is down 0.5% on Jun 10, 2025 14:51

• The overall market sentiment is bearish today.
• The bearish movement in CAH stock could be attributed to the announcement of a distribution services agreement between Citius Pharmaceuticals and Cardinal Health. This partnership might have raised concerns among investors about potential competition or changes in Cardinal Health's business strategy, leading to a negative impact on CAH stock price.

CAH Price Chart

CAH Technical Analysis

CAH News

Citius Pharmaceuticals Stock Is Soaring Monday: What's Going On? - Citius Pharmaceuticals ( NASDAQ:CTXR )

Citius announces a distribution services agreement with Cardinal Health. Cardinal serves as an authorized distributor of record for Citius Oncology, providing specialty pharmaceutical distribution services. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy ...

https://www.benzinga.com/trading-ideas/movers/25/06/45845271/citius-pharmaceuticals-stock-is-soaring-monday-whats-going-on

Trending Today

Pepe ($PEPE) Crypto Forecast: Down 7.8% Today

Pendle ($PENDLE) Crypto Forecast: Up 6.0% Today

Bitcoin Cash ($BCH) Crypto Forecast: Up 5.2% Today

Bitcoin SV ($BSV) Crypto Forecast: Up 5.1% Today

Arbitrum ($ARB) Crypto Forecast: Up 5.7% Today

Cardano ($ADA) Crypto Forecast: Up 5.4% Today

Ethereum ($ETH) Crypto Forecast: Up 5.1% Today

XRP ($XRP) Crypto Forecast: Up 6.9% Today

Coinbase Global Inc. ($COIN) Stock Forecast: Up 5.3% Today

Bumble Inc. ($BMBL) Stock Forecast: Up 5.2% Today

Cardinal Health Inc. Price History

01.10.2024 - CAH Stock was up 6.4%

• In the first quarter of 2025, Cardinal Health (CAH) posted strong results, surpassing adjusted EPS expectations and outperforming sales consensus. The success was mainly attributed to the robust performance of its drug distribution business.
• By revising its profit outlook for 2025 upwards, the company demonstrates confidence in its growth path and ability to seize opportunities within the healthcare industry.
• Following the impressive earnings announcement, the market reacted positively to Cardinal Health, resulting in a bullish trend in the stock price. Investors appreciated the company's solid financial performance and strategic efforts to navigate supply chain obstacles.

01.10.2024 - CAH Stock was up 6.3%

• Cardinal Health (CAH) experienced a strong bullish movement today following its Q1 earnings report:
• The company beat expectations with first-quarter fiscal 2025 results, driven by solid growth in Pharmaceutical and Specialty Solutions.
• Despite a decrease in sales due to the OptumRx contract expiry, the raised earnings per share (EPS) outlook for 2025 boosted investor confidence.
• The positive market reaction can be attributed to:
• Strong performance in the drug distribution business, leading to an increase in adjusted operating earnings.
• Continued growth prospects supported by new facilities, acquisitions, and overcoming supply chain challenges.
• The market's focus on CAH's robust financial performance overshadowed concerns about sector comparisons and potential competition from other medical stocks like Atossa Genetics (ATOS).
• Overall, Cardinal Health's resilience and strategic initiatives in the healthcare sector have positioned the company favorably, driving investor optimism and contributing to today's bullish market movement.

31.00.2025 - CAH Stock was down 5.4%

• CAH reported strong Q2 earnings and sales that exceeded expectations, with an increase in the 2025 EPS view. Still, the negative impact of the OptumRx contract expiry on Pharmaceutical segment sales likely contributed to the bearish movement.
• The news of a Congress member buying up to $15K in Cardinal Health stock may have added some uncertainty or negative sentiment to the market, influencing the stock's downward trend.
• Despite solid revenue growth in the Other segment and increased sales in branded and specialty pharmaceuticals, concerns about the OptumRx contract expiry and supply-chain challenges may have overshadowed positive developments.
• Investors may approach Cardinal Health cautiously due to recent events and uncertainties surrounding the company's key segments and contracts.

06.00.2025 - CAH Stock was down 1.3%

• Despite CAH's strong quarterly results and robust product portfolio, the stock experienced a -1.02% decline in the most recent trading session.
• The market movement could be attributed to profit-taking by investors after a period of growth, leading to a temporary dip in the stock price.
• Investors might be reacting to broader market trends or sector-specific news impacting healthcare companies, causing a negative sentiment towards CAH in today's trading.

30.00.2025 - CAH Stock was up 0.0%

• The positive anticipation surrounding its upcoming Q2 earnings report, with growth in branded and specialty pharmaceutical sales expected to drive performance, could be a factor in the recent bullish movement in CAH.
• Market sentiment might have been influenced by a Congress member's purchase of Cardinal Health stock, signaling confidence in the company's future prospects.
• Contributing to the upward momentum in CAH's stock price could be the overall bullish trend in the market and the company hitting a 52-week high.

04.03.2025 - CAH Stock was down 5.6%

• CAH stock fell by 1.14% in the latest trading session.
• This downward movement could be related to market volatility or negative factors affecting the healthcare industry.
• Investors may be responding to worries about regulatory adjustments or changes in consumer healthcare demands.
• Traders should stay updated on company-specific updates and broader market patterns when considering CAH's stock.

11.11.2024 - CAH Stock was down 1.4%

• The strength in CAH's pharmaceutical segment and diversified product portfolio was not enough to counterbalance the challenges of concentrated revenue generation and regulatory setbacks.
• Concerns about concentrated revenue generation and regulatory setbacks seemed to heavily influence investor sentiment, causing a decline in CAH's stock.
• Despite the positive aspects of the company's business segments, challenges mentioned earlier seemed to overshadow potential gains, resulting in today's bearish market movement for CAH.

15.06.2024 - CAH Stock was down 0.7%

• The bearish movement in CAH stock today could be attributed to regulatory setbacks. Regulatory challenges can impact the company's operations and profitability, leading to negative investor sentiment.
• Despite being highlighted as an undervalued dividend stock, the market might be reacting to specific concerns, overshadowing the potential long-term benefits of investing in dividend stocks.
• The overall market improvement may have had a limited impact on CAH stock, indicating that company-specific factors are currently driving the stock price movement more significantly than broader market trends.
• Investors should closely monitor any updates regarding regulatory issues and how Cardinal Health addresses them to gauge the future trajectory of the stock.

14.07.2024 - CAH Stock was up 5.1%

• Cardinal Health Inc.'s stock experienced a strong bullish movement today.
• The surprising 11% stock rally can be attributed to the company exceeding fourth-quarter earnings and revenue estimates, driven by strong sales of pharmaceuticals.
• The positive earnings report, where Cardinal Health beat EPS and revenue expectations, along with raising its EPS guidance for fiscal 2024, likely fueled investor optimism and contributed to the bullish market movement.
• The market's positive reaction indicates investor confidence in Cardinal Health's financial performance and outlook, positioning the company favorably in the healthcare services sector.

14.07.2024 - CAH Stock was up 5.9%

• Cardinal Health (CAH) surpassed expectations on Q4 earnings and raised its EPS guidance for fiscal 2024, showcasing solid profit growth in Pharmaceutical and Specialty Solutions.
• The robust Q4 results and raised outlook contributed to the positive market sentiment towards CAH stock.
• The strong performance of Cardinal Health overshadowed concerns in the healthcare sector, as indicated by the warning of potential crashes in other health care stocks.
• Overall, the optimistic outlook and financial performance of Cardinal Health drove the bullish movement in its stock, demonstrating investor confidence in the company's future prospects.

14.07.2024 - CAH Stock was up 5.0%

• Fourth-quarter 2024 adjusted EPS for Cardinal Health was reported at $1.84, showing a 29% increase year over year and surpassing consensus expectations. This positive earnings report likely contributed to the bullish movement in the stock.
• The company raised its fiscal 2025 adjusted earnings forecast above market expectations, indicating strong performance and future growth prospects.
• The market reacted positively to Cardinal Health's profit in the fourth quarter and its plans for a buyback, resulting in a more than 7% increase in the stock price during pre-market trading.
• The overall positive sentiment towards Cardinal Health, coupled with its strong financial performance and strategic initiatives, drove the stock to a bullish trajectory today.

10.05.2025 - CAH Stock was down 0.5%

• The overall market sentiment is bearish today.
• The bearish movement in CAH stock could be attributed to the announcement of a distribution services agreement between Citius Pharmaceuticals and Cardinal Health. This partnership might have raised concerns among investors about potential competition or changes in Cardinal Health's business strategy, leading to a negative impact on CAH stock price.